Bellicum Pharma: FDA lifts hold on U.S. trials of cancer drug

Bellicum Pharmaceuticals

11/04/2018 21:47

** Drug developer's shares  BLCM.O  up 16.1 pct at $7.95 in
after-hours trade
    ** FDA lifts hold on U.S. trials of co's experimental cancer
drug BPX-501  urn:newsml:reuters.com:*:nGNX5NgtQr
    ** Co says decision follows consultation with FDA and
agreement on amendments to study protocols including guidance on
monitoring and management of neurological adverse events
    ** In Jan, FDA placed a clinical hold on U.S. trials of the
cancer drug after three cases of brain disease linked to head
trauma  urn:newsml:reuters.com:*:nL4N1PP64T
    ** Up to Wednesday's close, stock had fallen ~19 pct this
year

 (Reporting by Akankshita Mukhopadhyay in Bengaluru)
 ((Akankshita.Mukhopadhyay@thomsonreuters.com))